Masimo Long Term Debt 2011-2025 | MASI
Masimo long term debt from 2011 to 2025. Long term debt can be defined as the sum of all long term debt fields.
- Masimo long term debt for the quarter ending September 30, 2025 was $0.559B, a 23.75% decline year-over-year.
- Masimo long term debt for 2024 was $0.728B, a 16.5% decline from 2023.
- Masimo long term debt for 2023 was $0.872B, a 7.42% decline from 2022.
- Masimo long term debt for 2022 was $0.942B, a 0% decline from 2021.
|
Masimo Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $728 |
| 2023 | $872 |
| 2022 | $942 |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | $185 |
| 2014 | $125 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $0 |
| 2010 | $0 |
|
Masimo Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-09-30 | $559 |
| 2025-06-30 | $599 |
| 2025-03-31 | $636 |
| 2024-12-31 | $714 |
| 2024-09-30 | $733 |
| 2024-06-30 | $747 |
| 2024-03-31 | $841 |
| 2023-12-31 | $872 |
| 2023-09-30 | $910 |
| 2023-06-30 | $889 |
| 2023-03-31 | $898 |
| 2022-12-31 | $942 |
| 2022-09-30 | $951 |
| 2022-06-30 | $922 |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | $153 |
| 2016-06-30 | $175 |
| 2016-03-31 | $225 |
| 2015-12-31 | $185 |
| 2015-09-30 | $190 |
| 2015-06-30 | $178 |
| 2015-03-31 | $125 |
| 2014-12-31 | $125 |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $0 |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| 2013-03-31 | $0 |
| 2012-12-31 | $0 |
| 2012-09-30 | $0 |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | $0 |
| 2011-09-30 | $0 |
| 2011-06-30 | $0 |
| 2011-03-31 | $0 |
| 2010-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.431B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $215.010B | 25.55 |
| Intuitive Surgical (ISRG) | United States | $194.409B | 76.06 |
| IDEXX Laboratories (IDXX) | United States | $56.231B | 55.84 |
| Edwards Lifesciences (EW) | United States | $48.211B | 32.33 |
| Alcon (ALC) | Switzerland | $38.868B | 26.27 |
| IQVIA Holdings (IQV) | United States | $37.851B | 21.11 |
| Mettler-Toledo (MTD) | United States | $28.469B | 33.31 |
| DexCom (DXCM) | United States | $26.115B | 36.00 |
| STERIS (STE) | Ireland | $24.712B | 25.51 |
| Waters (WAT) | United States | $22.941B | 30.34 |
| Hologic (HOLX) | United States | $16.718B | 17.56 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.969B | 0.00 |
| Penumbra (PEN) | United States | $12.219B | 85.96 |
| Globus Medical (GMED) | United States | $11.604B | 24.35 |
| Glaukos (GKOS) | United States | $6.254B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.835B | 18.54 |
| Teleflex (TFX) | United States | $5.607B | 8.94 |
| TransMedics (TMDX) | United States | $4.333B | 51.33 |
| LivaNova (LIVN) | United Kingdom | $3.427B | 18.51 |
| Veracyte (VCYT) | United States | $3.386B | 38.59 |
| Alphatec Holdings (ATEC) | United States | $2.965B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.548B | 11.96 |
| Elekta AB (EKTAY) | Sweden | $2.183B | 20.42 |
| Artivion (AORT) | United States | $2.138B | 98.09 |
| PROCEPT BioRobotics (PRCT) | United States | $2.011B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.826B | 15.94 |
| UFP Technologies (UFPT) | United States | $1.692B | 22.35 |
| Tandem Diabetes Care (TNDM) | United States | $1.450B | 0.00 |
| AxoGen (AXGN) | United States | $1.402B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.310B | 0.00 |
| IRadimed (IRMD) | United States | $1.224B | 58.32 |
| OPKO Health (OPK) | United States | $1.059B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.045B | 5.66 |
| Pulse Biosciences (PLSE) | United States | $0.965B | 0.00 |
| SiBone (SIBN) | United States | $0.807B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.640B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.621B | 36.13 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.613B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.545B | 10.88 |
| AngioDynamics (ANGO) | United States | $0.541B | 0.00 |
| NeuroPace (NPCE) | United States | $0.539B | 0.00 |
| RxSight (RXST) | United States | $0.519B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.441B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.429B | 11.86 |
| Alpha Tau Medical (DRTS) | Israel | $0.428B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.428B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.366B | 61.00 |
| ClearPoint Neuro (CLPT) | United States | $0.361B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.275B | 2.05 |
| Spectral Diagnostics (EDTXF) | Canada | $0.269B | 0.00 |
| CVRx (CVRX) | United States | $0.221B | 0.00 |
| 908 Devices (MASS) | United States | $0.216B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.211B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.205B | 0.00 |
| Inogen (INGN) | United States | $0.192B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.178B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.162B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.161B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.160B | 0.00 |
| Solana (HSDT) | United States | $0.139B | 0.00 |
| LENSAR (LNSR) | United States | $0.137B | 0.00 |
| Accuray (ARAY) | United States | $0.120B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.109B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.108B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Neuronetics (STIM) | United States | $0.104B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| InspireMD (NSPR) | United States | $0.083B | 0.00 |
| DarioHealth (DRIO) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Spectral AI (MDAI) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.037B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.023B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.35 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |